OSTEONIC CO., LTD. Financials Osteonic Co., Ltd.
Equities
A226400
KR7226400000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,350 KRW | +1.87% |
|
-1.58% | -9.75% |
| 2023 | Tranche Update on OSTEONIC Co., Ltd.'s Equity Buyback Plan announced on October 24, 2022. | CI |
| 2023 | Tranche Update on OSTEONIC Co., Ltd.'s Equity Buyback Plan announced on October 24, 2022. | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 59,796 | 55,111 | 95,445 |
| Enterprise Value (EV) 1 | 51,758 | 52,112 | 92,663 |
| P/E ratio | -19.5 x | 677 x | 25.1 x |
| Yield | - | - | - |
| Capitalization / Revenue | 3.83 x | 2.78 x | 3.43 x |
| EV / Revenue | 3.32 x | 2.63 x | 3.33 x |
| EV / EBITDA | 18.5 x | 10.5 x | 12.3 x |
| EV / FCF | - | -11,838,597 x | -8,812,949 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 1.69 x | 1.45 x | 1.84 x |
| Nbr of stocks (in thousands) | 16,773 | 17,413 | 19,802 |
| Reference price 2 | 3,565 | 3,165 | 4,820 |
| Announcement Date | 23/03/23 | 23/03/23 | 21/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 15,598 | 19,839 | 27,799 |
| EBITDA 1 | 2,793 | 4,942 | 7,550 |
| EBIT 1 | 579.4 | 2,526 | 4,843 |
| Operating Margin | 3.71% | 12.73% | 17.42% |
| Earnings before Tax (EBT) 1 | -5,438 | 2,081 | 1,781 |
| Net income 1 | -2,852 | 835.5 | 3,658 |
| Net margin | -18.28% | 4.21% | 13.16% |
| EPS 2 | -183.0 | 4.674 | 191.8 |
| Free Cash Flow | - | -4,402 | -10,514 |
| FCF margin | - | -22.19% | -37.82% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 23/03/23 | 23/03/23 | 21/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|
| Net sales | 5.114 | 6.215 | - |
| EBITDA | - | - | - |
| EBIT | - | 2.167 | - |
| Operating Margin | - | 34.86% | - |
| Earnings before Tax (EBT) | - | - | - |
| Net income 1 | 0.0231 | - | -0.8508 |
| Net margin | 0.45% | - | - |
| EPS 2 | - | - | -51.00 |
| Dividend per Share | - | - | - |
| Announcement Date | 29/11/22 | 13/02/23 | 29/05/23 |
1KRW in Billions2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | - | - |
| Net Cash position 1 | 8,038 | 2,999 | 2,782 |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -4,402 | -10,514 |
| ROE (net income / shareholders' equity) | - | 2.32% | 8.28% |
| ROA (Net income/ Total Assets) | - | 2.51% | 4.54% |
| Assets 1 | - | 33,260 | 80,528 |
| Book Value Per Share 2 | 2,107 | 2,190 | 2,620 |
| Cash Flow per Share 2 | 560.0 | 738.0 | 209.0 |
| Capex 1 | 939 | 481 | 6,108 |
| Capex / Sales | 6.02% | 2.43% | 21.97% |
| Announcement Date | 23/03/23 | 23/03/23 | 21/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.75% | 62.29M | |
| +13.73% | 130B | |
| -8.17% | 10.99B | |
| -4.33% | 8.35B | |
| +41.80% | 5.67B | |
| -21.94% | 4.72B | |
| +7.81% | 3.42B | |
| -10.26% | 2.76B | |
| -10.29% | 2.11B | |
| -13.58% | 1.92B |
- Stock Market
- Equities
- A226400 Stock
- Financials Osteonic Co., Ltd.
